Alto Neuroscience Announces $120 Million Private Placement Financing

MOUNTAIN VIEW, Calif .-- (BUSINESS WIRE) ---- $anro #cns--Alto Neuroscience, Inc. ("Alto†) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, announced today that it has entered into a securities purchase agreement with institutional and accredited investors to sell securities in a private placement financing (the "PIPE†) for gross proceeds of approximately $120 million, before deducting offering expenses. The ...